Example: Heart Attack

Clinical Trials Sponsored by Medicure

Total 8 results

    • NCT04706013
      Not yet recruiting
      Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
      Conditions: Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
    • NCT01766154
      Completed
      Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function
      Conditions: Renal Insufficiency
    • NCT01522417
      Completed
      Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
      Conditions: Myocardial Infarction; Acute Coronary Syndromes; Unstable Angina
    • NCT01245725
      Withdrawn
      Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
      Conditions: Myocardial Infarction; Acute Coronary Syndromes; Unstable Angina; Percutaneous Coronary Intervention
    • NCT00917293
      Terminated
      Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
      Conditions: Tardive Dyskinesia
    • NCT00402506
      Completed
      A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
      Conditions: Coronary Artery Bypass Graft Surgery; Myocardial Ischemia; Reperfusion Injury
    • NCT00157729
      Completed
      MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)
      Conditions: Diabetes Mellitus Type 2; Hypertension; Metabolic Syndrome
    • NCT00157716
      Completed
      MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)
      Conditions: Coronary Artery Bypass Graft Surgery; Myocardial Ischemia; Reperfusion Injury; Myocardial Revascularization
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations